Why is "Chemotherapy" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-08 16:41:16
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Chemotherapy is the type of cancer treatment that uses one or more anti-cancer drugs in a standard regimen. Chemotherapy may be given with a curative intent, or it may aim only to prolong life or to reduce symptoms. Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
New AI Test Estimates Individualized Chemotherapy Benefit in Breast Cancer Patients - Clinical Lab Products
-
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial - Nature
-
The future of cancer research may lie in tricking the immune system, UT researchers say - Houston Public Media
-
Immunotherapy boosts chemotherapy in combating stage 3 colon cancer - Mayo Clinic News Network
-
Can MRI Curb Chemo Overtreatment in Breast Cancer? - Medscape
-
Trends and Opportunities in the Chemotherapy-At-Home - GlobeNewswire
-
Male Breast Cancer Tool Predicts Chemotherapy Benefit - European Medical Journal
-
Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer - Business Wire
-
Atezolizumab Plus Chemotherapy Improves DFS in dMMR Colon Cancer - Targeted Oncology
-
Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery - The ASCO Post
-
AI model can predict chemotherapy benefit in breast cancer - Medical Xpress
-
What Is Combination Therapy for Lung Cancer? - Yale Medicine
-
Osimertinib Plus Chemotherapy Doubles PFS in EGFR-, TP53-Mutant Advanced NSCLC - OncLive
-
Chemotherapy Thrombocytopenia Romiplostim Maintains GI Treatment - Clinical Oncology News
-
What Changed Immunotherapy in Bladder Cancer - Oncodaily
-
Light-Activated Copper Therapy Targets Tumors - Technology Networks
-
Lifestyle Factors Shape Breast Cancer Chemotherapy Outcomes - European Medical Journal
-
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53 -mutant clonal hematopoiesis - Nature
-
Breast Cancer Recurrence Remains Low Even After 10 Years With Radiotherapy Tailored to Patient’s Individual Risk - The ASCO Post
-
Immunotherapy plus chemotherapy improves outcomes in stage III dMMR colon cancer - News-Medical
-
Immunotherapy is important to cancer treatment - Antigo Daily Journal
-
Mom of 2 Thought Her Arm Hurt from 'Sleeping Funny.' Then a 'Lightning Bolt' in Her Vision Made Her Call a Doctor - People.com
-
Moving Through Cancer Treatment: How Exercise Helps Women with Breast Cancer During Chemotherapy - University of Miami
-
Israeli researchers develop AI tool to predict chemotherapy benefit - CTech
-
Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer - UCLA Health
-
EMA OKs Two Treatments for Small Cell Lung Cancer - Medscape
-
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC - Medscape
-
Toxic Erythema of Chemotherapy - NEJM
-
High-dose chemotherapy in male germ cell cancer patients—a study by the SWENOTECA group - Nature
-
Mayo Clinic Q&A: What should I know about today’s chemotherapy? - Mayo Clinic News Network
-
New drug may trick the immune system into attacking cancer - futurity.org
-
Getting Chemotherapy While in a Nursing Home - Center for Medicare Advocacy
-
Update Shows Sustained OS Benefit With IMNN-001 in Ovarian Cancer - Targeted Oncology
-
Gene Aberrations Linked to Chemo Response in Japan - Bioengineer.org
-
Like ‘driving to San Francisco and back, every week’: In rural America, cancer patients face tall hurdles to get care - CNN
-
Mayo Clinic study finds chemotherapy before surgery improves survival in early-stage pancreatic cancer - Mayo Clinic News Network
-
Early-Onset CRC: Thinking Beyond the Tumor - Targeted Oncology
-
Laparoscopic Versus Open Surgery for Advanced-Stage Ovarian Cancer: A 10-Year Data Analysis - Cureus
-
Osimertinib Plus Chemotherapy Improves Outcomes in EGFR/TP53 mutant NSCLC: The TOP Study - Oncodaily
-
New biomarker predicts chemotherapy response in triple-negative breast cancer - UT MD Anderson
-
Hillsborough Family Seeks Help After Moms Stage 4 Colorectal Cancer Diagnosis - Patch
-
Adding Chemo to Osimertinib (Tagrisso) Doubles PFS in EGFR-Mutated NSCLC With TP53 Mutations - Oncology News Central
-
Tagrisso Plus Chemo Extends Time Without Cancer Growth in NSCLC - Cure Today
-
CHMP Recommends Tarlatamab for Relapsed ES-SCLC - OncLive
-
The long-term effects of chemotherapy on normal blood cells - Nature
-
Bacterial strain breaks decades-old bottleneck in chemotherapy drug manufacturing - Phys.org
-
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer - Nature
-
Chloroquine Overcomes Chemotherapy Resistance and Suppresses Cancer Metastasis by Eradicating Dormant Cancer Cells | Cell Death & Disease - Nature
-
The Targeted Pulse: FDA Updates and Conference Highlights - Targeted Oncology
-
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients - Penn Medicine
-
AI tool developed at Technion could transform how doctors decide on chemotherapy - ynetnews
-
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC - NEJM
-
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma - Northwestern University
-
Managing Chemotherapy Side Effects - CU Anschutz newsroom
-
Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responses - Nature
-
Chemotherapy modulates PD-L1 expression and its combination with immune checkpoint blockade requires precision - sciencedirect.com
-
Refugee detained by ICE missed vital chemo sessions and is now on his deathbed, family says - independent.co.uk
-
Success Rate of Chemotherapy for Lung Cancer: What Patients Need to Know in 2025 - Oncodaily
-
Blood tests may predict lymphoma treatment response - futurity.org
-
The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review - Nature
-
2025 Archive - Maryland School of Medicine
-
Can Radiotherapy “Wake Up” The Immune System In Pancreatic Cancer 2026 ? - Oncodaily
-
“Bottlebrush” particles deliver big chemotherapy payloads directly to cancer cells - MIT News
-
Giving Less Chemotherapy Can Still Cure Lymphoma Patients in their 80s, Study Says | URMC Newsroom - University of Rochester Medical Center
-
What We Thought We Knew About the Thymus May Be Wrong - Medscape
-
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial - The Lancet
-
Medical student studies genetic risks of chemotherapy drugs - Virginia Tech News
-
Adding chemotherapy to radiation causes greater short-term decline in quality of life for patients with cervical cancer - UCLA Health
-
Unintended chemotherapy consequences can drive drug resistance - Nature
-
Exploring Touch in Chemotherapy-Induced Neuropathy Relief - Bioengineer.org
-
Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling - Nature
-
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature
-
Scientists Identify a Molecular Switch to a Painful Side Effect of Chemotherapy - WCM Newsroom
-
Detained by ICE, he missed multiple cancer treatments. Now he’s in hospice. - startribune.com
-
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells | Cell Death & Disease - Nature
-
Tagrisso plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer - AstraZeneca
-
Exercising Through Breast Cancer: How One Powerlifter Defied Chemotherapy with Strength Training - University of Miami
-
New Strategy Doubles Chemo Effectiveness in Treatment-Resistant Cancer - Northwestern University
-
Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy - Nature
-
Predictors of chemotherapy-related unplanned acute care in outpatients receiving oral anticancer drugs - Nature
-
Tagrisso plus chemotherapy demonstrated a median overall survival of nearly four years, the longest benefit ever reported in a global Phase III trial in EGFR-mutated advanced lung cancer - AstraZeneca
-
Influence of capping chemotherapy prescriptions on efficacy and tolerability in medium and high-risk early-stage breast cancer - Nature
-
Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer - Nature
-
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma - Nature
-
What Is FOLFOX Chemo, and How Does It Work? - City of Hope
-
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer - Nature
-
Personalizing Chemotherapy in Metastatic Pancreatic Cancer - ASCO Publications
-
How Chemotherapy Affects Cancer and Normal Cells: Mechanisms, Side Effects and Long-Term Risks - Oncodaily
-
iXCells Biotechnologies joins international collaboration to evaluate chemotherapeutic toxicity in human organoids - News-Medical
-
Preserving hair and dignity: Maryland seeks to make scalp cooling more accessible for cancer patients - The Avenue News
-
Predicting resistance to chemotherapy using chromosomal instability signatures - Nature
-
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial - The Lancet
-
Delay-aware chemotherapy dosing via online critic learning - Nature
-
Link Between Tumor Metabolism, Drug Efficacy in Cancer Cells May Help Advance Precision Chemotherapy - SBU News
-
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China - The Lancet
-
GLP-1 Receptor Agonists in Cancer Care: Oncology Pharmacists Weigh Benefits, Risks, and Real-World Complexities - Pharmacy Times
-
A drug already in trials may stop chemotherapy nerve damage - ScienceDaily
-
Antibody-Drug Conjugate for Endocrine-Refractory and Chemotherapy Naive HR+, HER2- Breast Cancer - Memorial Sloan Kettering Cancer Center
-
Ultrasound-triggered chemotherapy to reduce side-effects - healthcare-in-europe.com
-
Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.